Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 421-750-9 | CAS number: 57280-22-5 TRIOXABICYCLOOCTAN; TRIOXABICYCLOOCTANE
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Study conducted according to OECD test guideline 401,male and female rats (5/sex/group) were treated with 2000 mg/kg bw of the test item by oral gavage, result: not classified
Study conducted according to OECD test guideline 402,groups of young adult Wistar rats (3/sex) were dermally exposed to Trioxabicyclooctan (100 % a.i) in 0.9% NaCl (750 mg/mL) for 24 hours at dose of 2000 mg/kg bw, result: not classified
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- February 1987
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Mol:WIST
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Mollegaard Breeding Centre Ltd, Ejby, DK-4623 Ll. Skensved.
- Age at study initiation: 5-6 weeks
- Weight at study initiation: 144-151 g
- Fasting period before study: 18 h
- Housing: The rats were individually ear-tagged and kept in Macrolone cages Type III (42 x 26 x 15 cm) 2 or 3 to a cage,· males and females separated. The bedding was softwood sawdust "Spanvall' Special White 11 from Spanvall Ltd, Jorlose, DK-4490 Jerslev.
- Diet (e.g. ad libitum): ad libitum, complete rodent diet ."Altromin 1314" from Chr. Petersen Ltd, DK-4100 Ringsted
- Water (e.g. ad libitum): tap water acidified with hydrochloric acid to pH 2.5, ad libitum
- Acclimation period: None
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21+/- 2
- Humidity (%): 55+/-15
- Air changes (per hr): 6
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg bw
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations: 1, 3 and 6 hours after administration and thereafter daily; weighing on day 0, 7, 14
- Necropsy of survivors performed: yes
- Clinical signs including body weight
- Other examinations performed: clinical signs, body weight - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Clinical signs:
- other:
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Since no rats died of the treatment the oral LD50 must exceed 2000 mg ",4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane"/kg b. wt.. According to Regulation (EU) No. 1727/2008 (CLP) the substance does not need to be classified with respect to acute oral toxicity.
- Executive summary:
In an acute oral toxicity study according to OECD test guideline 401 (1987), groups of fasted, Wistar rats (5/sex) were given a single oral dose of 4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane in water at a dose of 2000 mg/kg bw and observed for 14 days.
Oral LD50 Females/Males > 2000 mg/kg bw
After single oral administration of 4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane at 2000 mg/kg bw to male and female rats (5/sex/group) sedation and piloerection were found as clinical signs. At autopsy, no gross pathological organ changes were observed.
4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane is of LOW Toxicity based on the LD50 in female and male Wistar rats, thus, 4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane is not classified for acute oral toxicity according to Regulation (EU) No. 1272/2008 (CLP).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2002-02-18 to 2002-06-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 24 February 1987
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Shoe: WIST (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Tierzucht Schönwalde GmbH, Schönwalde, Germany
- Females (if applicable) nulliparous and non-pregnant: not specified
- Age at study initiation: not specified
- Weight at study initiation: males: 262-265 g; females: 198-209 g
- Housing: individually in conventional cages
- Diet (e.g. ad libitum): pell. Ssniff M-H ad libitum 24 hours per day
- Water (e.g. ad libitum): demineralized, acidified water, pH 2-3 ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-23
- Humidity (%): 52-62
- Photoperiod (hrs dark / hrs light): 12/12
- Type of coverage:
- semiocclusive
- Vehicle:
- physiological saline
- Details on dermal exposure:
- TEST SITE
- Type of wrap if used: patches
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): dermal administration of the substance solution at a dose of 2000 mg/kg using an administration volume of 0.53 - 0.72 mL.
- Concentration (if solution): 750 mg/mL - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations were performed 30 min, 1 hour, 3 hours and after > 6 hours after administration and then once daily until day 14. On day 14 a complete post mortem examination was performed. The application sites were evaluated 1, 24, 48 and 72 hours after removal of the patches. Additionally, in the three male animals the application site was also evaluated on day 6 of the study.
- Necropsy of survivors performed: yes
- Clinical signs including body weight
- Other examinations performed: clinical signs, body weight, gross pathology - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Clinical signs:
- other:
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to the system of evaluation recommended for EU, the mean values of findings relevant for classification at the time-points 1, 24, 48 and 72 hours after administration were 0 for swelling, reddening and scab formation.
- Executive summary:
In an acute dermal toxicity study according to OECD test guideline 402, groups of young adult Wistar rats (3/sex) were dermally exposed to Trioxabicyclooctan (100 % a.i) in 0.9% NaCl (750 mg/mL) for 24 hours at dose of 2000 mg/kg bw. Animals then were observed for 14 days.
Dermal LD50 Females/Males > 2000 mg/kg bw
Trioxabicyclooctan is of low to moderate Toxicity based on LD50 values in males and females. Based on these results the test item does not need to be classified according to Regulation (EU) No. 1272/2008 (CLP).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 000 mg/kg bw
Additional information
Acute oral toxicity:
In an acute oral toxicity study according to OECD test guideline 401 (1987), groups of fasted, Wistar rats (5/sex) were given a single oral dose of 4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane in water at a dose of 2000 mg/kg bw and observed for 14 days.
Oral LD50 Females/Males > 2000 mg/kg bw
After single oral administration of 4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane at 2000 mg/kg bw to male and female rats (5/sex/group) sedation and piloerection were found as clinical signs. At autopsy, no gross pathological organ changes were observed.
4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane is of LOW Toxicity based on the LD50 in female and male Wistar rats.
Acute dermal toxicity:
In an acute dermal toxicity study according to OECD test guideline 402, groups of young adult Wistar rats (3/sex) were dermally exposed to Trioxabicyclooctan (100 % a.i) in 0.9% NaCl (750 mg/mL) for 24 hours at dose of 2000 mg/kg bw. Animals then were observed for 14 days.
Dermal LD50 Females/Males > 2000 mg/kg bw
Trioxabicyclooctan is of low to moderate Toxicity based on LD50 values in males and females.
Justification for classification or non-classification
Based on the available information 4,4-dimethyl-3,5;8-trioxabicyclo(5.1.0)octane does not need to be classified for acute oral and dermal toxicity according to Regulation (EU) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.